|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | High plasma YKL-40 level in patients with ovarian cancer stage Ⅲ is related to shorter survival 显示文摘 | Hogdall EV Johansen JS Kjoer SK | 2003 | Oncol Rep2003，10，5： | 1 |
| 2 | Pre-treatment prediction of chemoresistance in second-line chemotherapy of ovarian carcinoma: value of serological tumor marker determination ( tet ranectin , YKL-40, CASA, CA 125)显示文摘 | Gronlund Bl Hogdall EV Christensen IJ | 2006 | Int J Biol Markers2006，21，3： | 1 |
| 3 | Evaluation of HFA, CA125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) as diagnostic tools of epithelial ovarian cancer in patients with a pelvic mass 显示文摘 | KARLSEN MA SANDHU N HOGDALL C | 2012 | Gynecol Oncol2012，127，2： | 1 |
| 4 | P53 autoantibodies in sera from Danish ovarian cancer patients and their correlation with clinical data and prognosis显示文摘 | Hogdall CK Blaakaer J | 2002 | APMIS2002，110，78： | 1 |
| 5 | Plasma YKL-40, as a prognostic tumor marker in recurrent ovarian cancer 显示文摘 | Dehn H Hogdall EV Johansen JS | 2003 | Acta Obstec Gynecol Scand2003，82，3： | 1 |
| 6 | YKL-40 tissue expres- sion and plasma levels in patients with ovarian cancer显示文摘 | Hogdall EV Ringsholt M Hogdall CK | 2009 | BMC Cancer2009，9，： | 1 |
| 7 | Distribution of HER -2 overexpression in ovarian carcinoma tissue andits prognostic value in patients with ovarian carcinoma: from the Danish MALOVA Ovarian Cancer Study显示文摘 | Hogdall EV Christensen L Kjaer SK | 2003 | Cancer2003，98，1： | 1 |
| 8 | Pretreatment predic- tion of chemoresistance in second-line chemotherapy of ovarian car- cinoma:value of serological tumor marker determination (tetranec- tin, YKL-40, CASA, CA125 ) 显示文摘 | Gronlund B Hogdall EV Johansen JS | 2006 | Int J Biol Markers2006，21，2： | 1 |
| 9 | Plasma YKL-40, as a prognostic tumor marker in recurrent ovarian cancer 显示文摘 | Dehn H Hogdall EV Johansen JS | 2003 | Acta Obstet Gynecol Scand2003，82，： | 1 |
| 10 | Cancer antigen 125 and prognosis显示文摘 | Hogdall E | 2008 | CurrOpin Obstet Gynecol2008，20，1： | 1 |
| 11 | YKL40 tissue expression and plasma levels in patients with ovarian cancer显示文摘 | Hogdall EV Ringsholt M Hogdall CK | 2009 | BMC Cancer2009，9，： | 1 |
| 12 | High plasma YKL-40 level in patients with ovarian cancer stage HI is related to shorter survival显示文摘 | Hogdall E V Johansen J S Kjaer S K | 2003 | Oncol Rep2003，10，5： | 1 |
| 13 | PreoperativeCA125 as a prognostic factor in stage I epithelial ovariancancer显示文摘 | Petri AL Hogdall E Christensen IJ | 2006 | APMIS2006，114，5： | 1 |
| 14 | Distribution of p53 expression in tissue from 774 Danish ovarian tumour patients and its prognostic significance inovarian carcinomas显示文摘 | Hogdall EV Christensen L Hogdall CK | 2008 | APMIS2008，116，5： | 1 |
| 15 | Efficacy of low-dose topotecan in second-line treatment for patients with epithelial ovarian carcinoma显示文摘 | Gronlund B Hansen HH Hogdall C | 2002 | Cancer2002，95，8： | 1 |
| 16 | Should CA-125 Response Criteria Be Preferred to Response Evaluation Criteria in Solid Tumors (RE CIST) for Prognostication During Second-Line Chemotherapy of Ovarian Carcinoma? 显示文摘 | Gronlund B Hogdall C Hilden J | 2004 | J Clin Oncol2004，22，20： | 1 |
| 17 | High plasma YKL-40 lev- el in patients with ovarian cancer stage Ⅲ is related to shorter sur- vival显示文摘 | Hogdall EV JohansenJS Kjaer SK | 2003 | Oncol Rep2003，10，5： | 1 |
| 18 | High plasma YKL-40 level in patients with ovarian cancer stage HI is related to shorter survival显示文摘 | Hogdall E V Johansen J S Kjaer S K | 2003 | Oncol Rep2003，10，5： | 1 |
| 19 | HE4 and CA125 levels in the preoperative assessment of endometrial cancer patients:a prospective multicenter study(ENDOMET)显示文摘 | Antonsen SL Hogdall E Christensen IJ | 2013 | Acta Obstet Gynecol Scand2013，92，11： | 1 |
| 20 | YKL-40 tissue expression and plasma levels in patients with ovarian cancer显示文摘 | Hogdall E V Ringsholt M Hgdall C K | 2009 | BMC Cancer2009，10，9： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员